$572 Million Decision Against Johnson & Johnson in Landmark Opioid Trial

The first case against a drug manufacturer for the national public health disaster may indicate what lies ahead in 2,000 more lawsuits. JAN HOFFMAN https://ift.tt/2Zrl5WP https://ift.tt/2PgtrRu The New York Times Health Opioids and Opiates, Drugs (Pharmaceuticals), Pain-Relieving Drugs, your-feed-healthcare August 26, 2019 at 02:00AM